Search

everythinglearnresearchcommunity

for

Search:↓

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Severe male pattern hair loss is linked to lower hair density in the back of the head.

Prolonged use of topical corticosteroids can cause excessive hair growth.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

Severe hair loss significantly worsens quality of life.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The man's scalp tightness after hair surgery affects his life and work, and it's unclear if it's due to the surgery or a mental health issue.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

PRP injections can increase hair density in people with androgenic alopecia.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.